Dr. Jeffrey Vacirca
Chairman of the Board & CEO
New York Cancer & Blood Specialists
Jeffrey Vacirca, MD, FACP is a board-certified hematologist and oncologist, serving as Chief Executive Officer and Chairman of the board at New York Cancer & Blood Specialists. Dr. Vacirca serves on the executive board of BeyondSpring Pharmaceuticals, Community Oncology Alliance (COA) and is the medical director for the International Oncology Network (ION), Oncology Network Development at Mt. Sinai Health Network, and for Long Island Aids Care (LIAC). Dr. Vacirca serves on the board of directors of Spectrum Pharmaceuticals, OneOncology, BeyondSpring, and the American Red Cross of Greater New York.
Dr. Vacirca is the founder and chairman of the New York Cancer Foundation, which provides financial assistance to patients undergoing cancer treatment. He is also co-founder and former vice-chairman of Odonate Therapeutics, and director and chair of the Compensation Committee of Spectrum Pharmaceuticals. Dr. Vacirca is the co-founder and president of the National Translational Research group.
Dr. Vacirca has received numerous awards and accolades for his efforts in providing outstanding patient care including Humanitarian of the Year by the American Red Cross, the Theodore Roosevelt Award for outstanding dedication to patient care, and being named in Newsday’s Top Doctors. Additionally, he was honored for his role in enabling LIAC staff to bring state of the art HIV testing to New York